Search research articles
Contact Us
Filters
Showing results (231-240 of 244) with videos related to
Page
of 25
Sort By:
Journal of Hematotherapy
|
December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery
C Faucher, A G Le Corroller, C Chabannon, et al.
Bone Marrow Transplantation
|
February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol
J-P Lotz, P Pautier, F Selle, et al.
Leukemia & Lymphoma
|
December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia
D Maraninchi, N Vey, P Viens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S Dawood, S D Merajver, P Viens, et al.
British Journal of Cancer
|
October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
P Viens, T Palangié, M Janvier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2012
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
A Gonçalves, M Gilabert, E François, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
F Bertucci, N T Ueno, P Finetti, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 244) with videos related to
Sort By:
Page
of 25
Journal of Hematotherapy
|
December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery
C Faucher, A G Le Corroller, C Chabannon, et al.
Bone Marrow Transplantation
|
February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol
J-P Lotz, P Pautier, F Selle, et al.
Leukemia & Lymphoma
|
December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia
D Maraninchi, N Vey, P Viens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S Dawood, S D Merajver, P Viens, et al.
British Journal of Cancer
|
October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
P Viens, T Palangié, M Janvier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2012
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
A Gonçalves, M Gilabert, E François, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
F Bertucci, N T Ueno, P Finetti, et al.
Page
of 25